Table 1.
Demographics and Mood Health
| Full Sample (n=40) | Follow-up Sample (n=28) | |||
|---|---|---|---|---|
| Mean (SD) | Mean (SD) | |||
| Age (years) | 16.05 (1.57) | 16.07 (1.78) | ||
| Depressive Symptoms (CESD Score) At Baseline | 18.43 (16.27) | 14.82 (15.45) | ||
| Depressive Symptoms (CESD Score) At Follow-up (Day 15) | 11.18 (11.17) | |||
| Max Negative Affect (short PANAS-N) Over Follow-up | 12.25 (3.78) | |||
| SD in Negative Affect (short PANAS-N) Over Follow-up | 2.09 (1.00) | |||
| Max Positive Affect (short PANAS-P) Over Follow-up | 14.29 (3.54) | |||
| SD in Positive Affect (short PANAS-P) Over Follow-up | 2.43 (1.06) | |||
| % | % | |||
| Gender | ||||
| Female | 72.5% | 82.1% | ||
| Male | 22.5% | 14.3% | ||
| Non-binary | 5.0% | 3.6% | ||
| Medication Use | ||||
| Norepinephrine-dopamine reuptake inhibitor | 12.5% | 10.7% | ||
| Selective serotonin-norepinephrine reuptake inhibitor | 10.0% | 7.1% | ||
| Selective serotonin reuptake inhibitor | 35.0% | 25.0% | ||
| Tetracyclics | 0.0% | 0.0% | ||
| Anticonvulsants/Antipsychotics | 15.0% | 7.1% | ||
| Lithium | 7.5% | 10.7% | ||
| Anxiolytics (non-Benzodiazepine) | 7.5% | 7.1% | ||
| Any psychoactive medication use | 40.0% | 32.1% | ||
| Race | ||||
| African American | 2.5% | 0.0% | ||
| American Indian/Alaskan Native | 0.0% | 0.0% | ||
| Asian | 10.0% | 14.3% | ||
| Biracial or Other | 12.5% | 7.1% | ||
| White | 75.0% | 78.6% | ||
| Ethnicity | ||||
| Hispanic | 2.5% | 3.6% | ||
| Not Hispanic or Other | 97.5% | 96.4% | ||
| Education (Parent Highest) | ||||
| Without High School Diploma | 0.0% | 0.0% | ||
| High School Graduate Without College Degree | 2.5% | 3.6% | ||
| Some College Education | 5.0% | 3.6% | ||
| Degree from Four-Year College (or more) | 92.5% | 92.8% | ||
| Current % | Life % | Current % | Life % | |
| Major Depressive Disorder (MDD) | 47.5% | 47.5% | 35.7% | 35.7% |
| Anxiety Disorders secondary to MDD | 15.0% | 15.0% | 17.9% | 17.9% |
| Posttraumatic Stress Disorder | 0.0% | 0.0% | 0.0% | 0.0% |
| Generalized Anxiety Disorder | 15.0% | 15.0% | 17.9% | 17.9% |
| Panic Disorder | 5.0% | 5.0% | 7.1% | 7.1% |
| Agoraphobia | 0.0% | 0.0% | 0.0% | 0.0% |
| Social Phobia | 2.5% | 2.5% | 3.6% | 3.6% |
| Specific Phobia | 0.0% | 0.0% | 0.0% | 0.0% |
| (Mild) Substance Use Disorders | 0.0% | 0.0% | 0.0% | 0.0% |
Note: Center for Epidemiological Studies Depression Scale (CESD), Maximum (Max), Positive and Negative Affect Schedule -Negative affect subscale, short version (PANAS-N, possible score range of 5 to 25), Positive and Negative Affect Schedule -Positive affect subscale, short version (PANAS-P, possible score range of 4 to 20), standard deviation (SD).